Background: Abdominal aortic calcification (AAC) is a marker of subclinical atherosclerotic disease and an independent predictor of subsequent vascular morbidity and mortality. Aim of the work: This study was conducted to investigate the association of abdominal aortic calcification with cardiac abnormalitiesin hemodialysispatient (HD). Methods: This cross-sectionalobservational study wasperformed on 90 patients (50 males and 40 females)with chronic kidney disease, stage 5 (CKD)of varying etiologies from hemodialysis unit at AlHussein UniversityHospital. They wereundergoing regularhemodialysis for more than 6 monthes.Laboratory investigations were done including liver function tests, kidney function tests,complete blood count (CBC),C-reactive protein (CRP), fasting and random blood glucose,lipid profile, calcium, phosphorus,calcium phosphate productandparathormone(PTH).In addition, Echocardiography and Xray plain radiography were determined. Results: Out of 90 HD patients, 37 patients (41.1 %) had valvular calcification, all of them (41.1 %) had aortic valve calcifications and AAC score exceeded 6. Only 7 patients (7.8%)had mitral valve calcifications. Moreover, cases with mitral valve calcifications had aortic valve calcification and AAC score above 12. Seven patients (7.8 %) had mildaortic regurgitation (AR)and 4 patients (4.44%) had aortic stenosis. Conclusion: AAC precedes the occurrence of cardiac abnormalities in HD patients and has been shown to have significant prognostic significance for cardiovascular events and mortality.
INTRODUCTION
Vascular calcification (VC) is a common complication associatedwith chronic kidney disease (CKD) and the major cause of cardiovascular disease (CVD) in the patients with end stage renal disease (ESRD) (1) .Furthermore, patients with chronic kidney disease exhibitaccelerated calcification of the intima, media, heart valves and likely the myocardium as well as the rare condition of calcificuraemic arteriolopathy (calciphylaxis) (2) . The prevalence of VC increases as CKD progresses, from 40 % at stage 3 CKD to 80-99 % at stage 5 CKD on dialysis . Mineral and bone disorder (MBD) is also a frequent complication of CKD associated with increased risk of VC, arterial dysfunction, morbidity and mortality
(4)
. A studies were revealed that every 1.0 mg/dL of serum phosphorus was associated with 18% increase of the risk of death in patients with CKD, indicating that hyperphosphatemia is an independant risk factor for mortality among those patients . In addition, hyperphosphatemia is a key regulator involved in multiple mechanisms that induce and promote the progression of VC. Therefore, prevention of MBD and lowering the circulating levels of phosphate and calcium have become major targets in the treatment of VC . Dialysed patients showed increased calcium deposition within the cardiac valve apparatus, namely aortic and mitral valves . As a matter of fact, haemodynamically significant aortic valve stenosis is more prevalent and accelerated in ESRD patients when compared with subjects with normal kidney function (8) . Calcification of the aortic and mitral valve on echocardiography has been linked to coronary atherosclerosis in the general population and carotid intima-media thickness (an indirect marker of atherosclerosis) among patients undergoing haemodialysis , suggesting that vascular andvalvular calcification might share common pathogenetic mechanisms (9) . Structural and functional cardiac abnormalities are common in patients with CKD. 70-80% of CKD-5D patients have abnormal left ventricular (LV) structure and/or function and 74% of CKD stage 5 patients show evidence of LV hypertrophy (LVH) at the initiation of renal replacement therapy (10) . Therefore, this study wasperformed to assess the abdominal aortic calcification and to find out its relation to cardiac abnormalities in HD patients.
PATIENTS AND METHODS
This study included 90 subjects.They were divided into three groups as follow: Group (I): Included 30 patients (9) males and (21) females with mean age (39.1 ±4.72 years) and with mean hemodialysis duration (38.63 ±58.17 months). Group (II):Included 60 patients (41) males and (19) females with mean age (51.92 ±4.17 years) and with mean hemodialysis duration (86 ±56.55 months). Group (II) were sub-classified into three subgroups based on AAC score as follow: Group IIa (score from 1 to 6) Included 34 patients (28) males and (6) females with mean age (52.4 ± 3.75 years) and with mean hemodialysis duration (61.97±47.2 months). Group IIb(score from 7 to 12) Included 19 patients (9) males and (10) females with mean age (51.1 ± 5.2 years)and with mean hemodialysis duration (98.5 ±44 months).Group IIc (score above 12) Included 7 patients (4) males and (3) females with mean age (52 ± 2.9 years)and with mean hemodialysis duration (173± 28 months).
* The protocol was explained to the patients and informed consent for all patients was obtained. This information on age, gender, duration of dialysis, diabetic status, and smoking (non-smoker, current or past smoker) of all patients on hemodialysis.
*The inclusion criteria were age ranged from 18 to 60yearswith CKD (stage 5 ) on maintenance heamodialysis for at least 12 month es.Exclusion criteria were patients with old myocardial infraction, rheumatic or congenital heart diseases and those with history of kidney transplantation.
* Laboratory investigations were done including liver function tests, kidney function tests, Hemoglobin percent (HB%), lipid profile, calcium, phosphorus, calcium phosphate product and parathormone (PTH). In addition, Echocardiography and Xray plain radiography were determined.
The study was done after approval of ethical board of Al-Azhar university and an informed written consent was taken from each participant in the study.
Statistical Analysis
Statistical analyses were performed using SPSS version20.0. Quantitative data were expressed as mean± sta ndard deviation (SD). Qualitative data were expressed as frequency a nd percentage.Indepndant t-test of segnificance was used when comparing between two mean. ANOVA test for comparing more than two groups.
RESULTS
A total of 90 patients on regular HD(50 males and 40 females) fulfilling the inclusion and exclusion criteriawere included into the study.14 patients had diabetes mellitus(DM)and 36 patientshad hypertension (HTN), while18 patients were smokers as shown in figures1,2 and only 15.55%were diabetics ( fig.1 ). In addition, 40% of the study population were hypertensive ( fig. 2) .Also, only20% of the study population were smokers( fig. 3) .Moreover, 37 patients (41.1 %) had valvular calcification and hadaortic valve calcifications with AAC score exceeded 6.
On the other hand,7 patients(7.8%) had mitral valve calcifications. Population with mitral valve calcifications had aortic valve calcification and AAC score above 12. Seven patients (7.8 %) had mild aortic regurgitation and 4 patients ( 4.44%) had aortic stenosis as shown in figure(4).Furthermore, patients without AAC had no valvular calcification either aortic or mitral. No patients had pulmonaryor tricuspid valve calcification. The duration of dialysis in group II patients was statistically significant higher than that of group I as shown in figure(5)and table (1). Moreover,the left ventricular end systolic diameter in group II patients (4.31 ± 1.01) was statistically significant higher than that of group I(3.48 ± 0.72). Also, the left ventricular end diastolic diameter in group II patients (5.84 ± 0.68) was statistically significant higher than that of group I (5.09 ± 0.43 )( Fig. 6& table 2 Independent t-test. Data were represented as mean + SD, P <0.05 significant.P<0.001 considered highly significant. p >0.05 considered non-significant (NS). 
DISCUSSION
Vascular calcification plays a major role in ca rdiovascular disease which is one of the main causes of mortality in chron ic kidney disease patients (11) .Thus, we demonstrated in our study a high prevalence of vascular calcification among ESRD patients on HD and showed that was correlated to the presence of cardiovascular disease. HD patients were classified into two groups according to thepresence or absence of valvular calcification.In the present study, patients with valvular calcificationhave high AAC score(p value=0.001). HD patients with valvular calcification were older in age, with a longer HD duration,showed normal phosphorus level and calcium x phosphorus products.These factors may be responsible for the development of cardiovascular diseas. However, a number of non-invasive imaging techniques have been developed for detection and quantification of vascular calcification. The simplest technique is lateral lumbar Xray plain radiography and is used to quantify Abdominal Aorta Calcification score (AACS). In our study, we found no significant correlations betweencalcification score and DM.This is not in agreement with Raggi P et al. who found that DM was associated with increasedvascular calcification indialysis patients (12) .This may be because of a little number of diabetic patients in our study.Furthermore, the current study showed that there was significantassociation between AACS and age, wherecalcification scoreincreased rapidly with age.Thiscomes in agreement withHonkanen H et al (13) .On the other hand, in this study there were other factors correlated withvascularcalcification (VC) such as phosphate level, triglycerides, parathyroid hormoneand dialysis adequacy. This factors notcorrelated uniformly withAACS. We particulary comment on the absence of strong correlations between phosphate level and AACS which is different from other previous studies (14) .This may be because of other confounding factors that may overshadow its statistical impact or relatively short period of phosphate monitoring inthisstudy. Ejection Fraction (EF) in our study not correlated positively with presence of valvular calcification.On the other hand, our study showed no significant association between serum calcium and PTH with both valvular calcification and AAC scoring.Our findings are in accordance withVolkovet al.who found that patients with valvular calcification receiving hemodialysis, had longer hemodialysis duration (15) .Also, our study was inconsistent withprevious study which was suggested that aortic and mitralvalvecalcification was associated with increased age.
